KALOSAR Trademark

Trademark Overview

On Tuesday, December 11, 2018, a trademark application was filed for KALOSAR with the United States Patent and Trademark Office. The USPTO has given the KALOSAR trademark a serial number of 88224364. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 18, 2022. This trademark is owned by Glenmark Pharmaceuticals Inc., USA. The KALOSAR trademark is filed in the Pharmaceutical Products category with the following description:

Dermatological preparations for the treatment of hyperproliferative diseases
kalosar

General Information

Serial Number88224364
Word MarkKALOSAR
Filing DateTuesday, December 11, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements

Goods and ServicesDermatological preparations for the treatment of hyperproliferative diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlenmark Pharmaceuticals Inc., USA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430
Party NameGlenmark Pharmaceuticals Inc., USA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMahwah, NJ 07430

Trademark Events

Event DateEvent Description
Monday, July 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 29, 2021SOU EXTENSION 5 GRANTED
Friday, November 19, 2021SOU EXTENSION 5 FILED
Monday, November 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 19, 2021TEAS EXTENSION RECEIVED
Tuesday, June 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 28, 2021SOU EXTENSION 4 GRANTED
Friday, May 28, 2021SOU EXTENSION 4 FILED
Friday, May 28, 2021TEAS EXTENSION RECEIVED
Thursday, December 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 1, 2020SOU EXTENSION 3 GRANTED
Tuesday, December 1, 2020SOU EXTENSION 3 FILED
Tuesday, December 1, 2020TEAS EXTENSION RECEIVED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 5, 2020SOU EXTENSION 2 GRANTED
Friday, June 5, 2020SOU EXTENSION 2 FILED
Friday, June 5, 2020TEAS EXTENSION RECEIVED
Thursday, November 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2019SOU EXTENSION 1 GRANTED
Tuesday, November 26, 2019SOU EXTENSION 1 FILED
Tuesday, November 26, 2019TEAS EXTENSION RECEIVED
Tuesday, June 11, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 9, 2019ASSIGNED TO EXAMINER
Thursday, January 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 14, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

kalosar diseases hyperproliferative treatment preparations dermatological